<DOC>
	<DOCNO>NCT01723124</DOCNO>
	<brief_summary>The purpose research evaluate whether repeat screen Molecular Breast Imaging ( MBI ) study two year initial screen MBI study improve breast cancer detection woman dense breast tissue .</brief_summary>
	<brief_title>Low-dose Molecular Breast Imaging : Comparison Breast Cancer Detection Rate Initial Screening Two-year Follow-up</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Radiopharmaceuticals</mesh_term>
	<criteria>Past prior screen mammogram within previous 1124 month interpret heterogeneously dense extremely dense negative benign [ Breast Imaging Reporting Data System ( BIRADS ) Category 1 2 ] Subjects exclude : Are unable understand sign consent form Are pregnant lactate Are physically unable sit upright still 40 minute Have selfreported sign symptom may suggest breast cancer ( palpable mass , bloody nipple discharge , axillary mass , etc . ) Have needle biopsy within 3 month , breast surgery radiation within 1 year prior study Are currently receive chemotherapy tamoxifen , raloxifene , aromatase inhibitor adjuvant therapy chemoprevention Have undergone bilateral mastectomy Have prior MBI within 20 month schedule study MBI .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Dense breast tissue</keyword>
	<keyword>breast cancer screen</keyword>
	<keyword>molecular breast imaging</keyword>
	<keyword>breast cancer</keyword>
	<keyword>breast</keyword>
</DOC>